A kind of transparent medical neutral borosilicate glass and preparation method thereof

By adjusting the glass raw material components and using the method of segmented temperature control heating, transparent medical neutral borosilicate glass with low linear thermal expansion coefficient and high chemical stability was prepared, which solved the problem of poor stability of existing neutral borosilicate glasses. , suitable for high-demand pharmaceutical packaging and biological products.

CN115321817BActive Publication Date: 2024-11-05CENT SOUTH UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211069109.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-09-02
Publication Date
2024-11-05
Estimated Expiration
2042-09-02

AI Technical Summary

Technical Problem

Existing neutral borosilicate glass has the problems of high thermal expansion coefficient and poor chemical stability, which limits its use in pharmaceutical packaging and other applications.

Method used

By adjusting the proportion of components in the glass raw materials, a variety of alkali metal and alkaline earth metal oxides were introduced, combined with a small amount of ZnO, the ratio of Na2O to K2O, ZnO and CaO was optimized, and NaCl was used as a clarifier and the temperature was controlled to increase the temperature in sections using segmented temperature control. Method for preparing transparent medical neutral borosilicate glass.

Benefits of technology

It significantly reduces the linear thermal expansion coefficient of the glass, improves chemical stability, meets international standards of water and acid resistance, and is suitable for packaging of pharmaceuticals and biological products.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115321817B_ABST
    Figure CN115321817B_ABST
Patent Text Reader

Abstract

The present invention provides a transparent medical neutral borosilicate glass and a preparation method thereof, belonging to the technical field of basic glass. The glass is prepared from a clarifier and glass raw materials, wherein the glass raw materials include SiO 2 , B 2 O 3 、Al 2 O 3 、Na 2 O.K 2 O, CaO and BaO; the clarifier is NaCl. In the present invention, multiple alkali metal and alkaline earth metal oxides are introduced. Compared with the introduction of a single network modifier, in a glass system containing multiple alkali metal ions, various metal ions will compete with each other to obtain the best oxygen coordination state, thereby making the network structure more compact and the macroscopic properties undergo nonlinear changes. The present invention obtains a neutral borosilicate glass with a lower thermal expansion coefficient and higher chemical stability by adjusting the amount of each component in the raw material.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of basic glass, and in particular to a transparent medical neutral borosilicate glass and a preparation method thereof. Background Art

[0002] Borosilicate glass refers to an amorphous homogeneous glass material prepared by introducing an appropriate amount of boron element as a network former into ordinary silicate glass through heat treatment. This glass has the advantages of strong thermal stability, excellent chemical stability, high mechanical strength, and low specific gravity. It has been widely used in food and drug packaging, electricity, electronics, machinery and other fields. Among them, neutral borosilicate glass is highly respected in the world in the packaging of liquid drugs and expensive preparations, and has an irreplaceable position.

[0003] The main properties of borosilicate glass depend to a large extent on its chemical composition. According to the different boron content, my country divides pharmaceutical glass into four types: soda-lime glass, low-borosilicate glass, 3.3 borosilicate glass and neutral glass. Among them, 3.3 borosilicate glass is less used due to its disadvantages such as greater difficulty in melting and higher working temperature. Currently, the widely used pharmaceutical packaging glasses are low-borosilicate glass and soda-lime glass. Both of them fail to meet international standards in the 98°C particle method water resistance test, which means that the properties of aqueous phase drugs may change due to long-term storage in this type of glass container. Moreover, its large linear thermal expansion coefficient limits the application range of the material and increases the difficulty of thermal processing. The neutral borosilicate glass in the prior art still has the problems of high linear thermal expansion coefficient and poor chemical stability. Summary of the invention

[0004] In view of this, the object of the present invention is to provide a transparent medical neutral borosilicate glass and a preparation method thereof. The transparent medical neutral borosilicate glass of the present invention has a low linear thermal expansion coefficient and extremely high chemical stability.

[0005] In order to achieve the above-mentioned object of the invention, the present invention provides the following technical solutions:

[0006] The present invention provides a transparent medical neutral borosilicate glass, which is prepared from a clarifier and glass raw materials, wherein the glass raw materials include the following components in percentage by mass:

[0007] 70.5-76.5% SiO2, 6.5-10.5% B2O3, 4-10% Al2O3, 0.5-6.8% Na2O, 0.5-6.8% K2O, 0-3.7% CaO and 0-3.7% BaO, wherein the mass percentage of BaO is not 0;

[0008] The clarifier is NaCl, the mass fraction of the NaCl is 0-2% of the glass raw material and the mass fraction of the NaCl is not 0.

[0009] Preferably, the glass raw material comprises the following components in percentage by mass:

[0010] 72.5-74.5% SiO2, 8.5-10.5% B2O3, 6-8% Al2O3, 4-6.8% Na2O, 0.5-1% K2O, 0-3% CaO and 0-2.7% BaO;

[0011] The mass fraction of the NaCl is 0-1% of the glass raw material.

[0012] Preferably, the glass raw material further comprises 0-3 wt % of ZnO, and the mass percentage of the ZnO is not 0.

[0013] Preferably, the glass raw material further comprises 0-1 wt % of ZnO.

[0014] Preferably, the mass ratio of Na2O to K2O is 12-14.

[0015] Preferably, the ratio of the sum of the masses of ZnO and CaO to the mass of BaO is 0.7-4.

[0016] The present invention also provides a method for preparing the transparent medical neutral borosilicate glass according to the above technical solution, comprising the following steps:

[0017] Mixing the glass raw materials and the clarifier and melting them to obtain a glass melt;

[0018] The glass melt is sequentially subjected to pouring, first cooling, annealing treatment and second cooling to obtain the transparent medical neutral borosilicate glass.

[0019] Preferably, the melting process is in the range of 25-700°C, with a heating rate of 3-4°C / min; in the range of 700-1200°C, with a heating rate of 4-5°C / min; in the range of 1200-1650°C, with a heating rate of 5-10°C / min, and the heat preservation time is 1.5-2.5h.

[0020] Preferably, the cooling rate of the first cooling is 700-800° C. / min.

[0021] Preferably, the annealing treatment is performed at a temperature of 580-600° C. and for a time of 2-3 hours.

[0022] The invention provides a transparent medical neutral borosilicate glass, which is prepared from a clarifier and glass raw materials. The glass raw materials include the following components in mass percentage: 70.5-76.5% of SiO2, 6.5-10.5% of B2O3, 4-10% of Al2O3, 0.5-6.8% of Na2O, 0.5-6.8% of K2O, 0-3.7% of CaO and 0-3.7% of BaO, and the mass percentage of the BaO is not 0; the clarifier is NaCl, the mass fraction of the NaCl is 0-2% of the glass raw materials, and the mass fraction of the NaCl is not 0.

[0023] In the present invention, multiple alkali metals (Na2O and K2O) and alkaline earth metal oxides (CaO and BaO) are introduced. Compared with the introduction of a single network modifier, in a glass system containing multiple alkali metal ions, various metal ions will compete with each other to obtain the best oxygen coordination state, thereby making the network structure more compact and the macroscopic properties undergo nonlinear changes. The present invention obtains neutral borosilicate glass with a lower thermal expansion coefficient and higher chemical stability by adjusting the amount of each component in the raw material.

[0024] Furthermore, the present invention introduces a small amount of ZnO to replace CaO to further improve the chemical stability without negatively affecting the thermal stability. ZnO is a network intermediate, and its specific role is related to its content. When the content is low, ZnO can be used as a body to strengthen the glass network, thereby reducing the probability of alkaline metal ions being dissolved, and improving acid resistance and water resistance. At the same time, due to Zn 2+ With large cation field strength, 2- The bond is stronger and has no negative impact on the water resistance of neutral borosilicate glass compared to other alkaline metal ions.

[0025] Furthermore, the present invention limits the mass ratio of Na2O to K2O to 12-14, and the ratio of the sum of the masses of ZnO and CaO to the mass of BaO to 0.7-4, optimizes the relative proportions of Na2O to K2O, ZnO and CaO to BaO, further reduces the thermal expansion coefficient, and improves the chemical stability.

[0026] Furthermore, the present invention introduces NaCl as a clarifier, which reduces bubble defects in the glass melting process without increasing the clarification temperature or extending the holding time, and at the same time ensures that the main properties are not negatively affected. NaCl can stably evaporate at 1450°C to form corresponding bubbles, while absorbing the primary bubbles remaining in the glass liquid, and then quickly diffuse to the surface of the glass liquid and release it into the furnace atmosphere to achieve a clarification effect.

[0027] The neutral borosilicate glass obtained by the present invention has a low thermal expansion coefficient (20-300°C), extremely high acid resistance, good alkali resistance, and excellent mechanical properties, and can be used as packaging materials for various injections, biological products, frozen preparations and high-end cosmetics; the water resistance of the present invention is defined as reaching Class 1 standard using the 98°C particle water resistance method, and is a neutral borosilicate glass that meets domestic and international standards.

[0028] The present invention also provides a method for preparing the transparent medical neutral borosilicate glass described in the above technical solution. The present invention designs a unique segmented temperature control heating system according to the chemical reaction rules between the raw materials in the glass melting process to reduce the problem of boron volatilization. B2O3 can increase the connectivity of the glass network structure and improve the main properties of the glass; however, its melting temperature is much lower than SiO2, and it may volatilize excessively during the melting process. A step-by-step variable speed heating method is adopted to ensure that B2O3 is fully combined with the alkali metal oxide component before volatilization. B2O3 combines with Na2O before 700°C to form various borates, such as sodium tetraborate, and the temperature is slowly increased at this stage to reduce boron loss at high temperatures. The preparation cost of the present invention is low, the environmental load is small, and it is conducive to industrial large-scale production. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 The following are actual pictures of the transparent medical neutral borosilicate glass prepared in Examples 1 to 4 of the present invention, wherein (1) is Example 1, (2) is Example 2, (3) is Example 3, and (4) is Example 4. DETAILED DESCRIPTION

[0030] The present invention provides a transparent medical neutral borosilicate glass, which is prepared from a clarifier and glass raw materials, wherein the glass raw materials include the following components in percentage by mass:

[0031] 70.5-76.5% SiO2, 6.5-10.5% B2O3, 4-10% Al2O3, 0.5-6.8% Na2O, 0.5-6.8% K2O, 0-3.7% CaO and 0-3.7% BaO, wherein the mass percentage of BaO is not 0;

[0032] The clarifier is NaCl, the mass fraction of the NaCl is 0-2% of the glass raw material and the mass fraction of the NaCl is not 0.

[0033] In the present invention, unless otherwise specified, the raw materials used are all commercially available products in the art.

[0034] In the present invention, the mass percentage of SiO2 in the glass raw material is preferably 72.5-74.5%, more preferably 73.5%.

[0035] In the present invention, the mass percentage of B2O3 in the glass raw material is preferably 8.5-10.5%, more preferably 9.5%.

[0036] In the present invention, the mass percentage of Al2O3 in the glass raw material is preferably 6-8%, more preferably 7%.

[0037] In the present invention, the mass percentage of Na2O in the glass raw material is preferably 4 to 6.8%.

[0038] In the present invention, the mass percentage of K2O in the glass raw material is preferably 0.5-1%.

[0039] In the present invention, the mass percentage of CaO in the glass raw material is preferably 0 to 3%, and more preferably 1.5%.

[0040] In the present invention, the mass percentage of BaO in the glass raw material is preferably 0 to 2.7%, more preferably 0.7 to 2.2%, and most preferably 1.7%.

[0041] In the present invention, the mass percentage of NaCl is preferably 0-1% of the glass raw material, more preferably 0.5%. NaCl is completely volatilized during the melting stage of the preparation method, so it is not considered as one of the glass components in the present invention, and its usage in the raw material is given in the form of an additive.

[0042] In the present invention, the glass raw material preferably includes the following components in mass percentage:

[0043] 72.5-74.5% SiO2, 8.5-10.5% B2O3, 6-8% Al2O3, 4-6.8% Na2O, 0.5-1% K2O, 0-3% CaO and 0-2.7% BaO.

[0044] The present invention uses a variety of network modifiers, and systematically replaces each other through them to obtain the best introduction ratio of each component in the raw material. Due to the obvious difference in the ion field strength of different cations, the co-introduction of multiple cations will trigger a multi-alkali effect, and various cations compete for the best coordination state, causing some properties of the glass to change nonlinearly, which can determine the most suitable introduction ratio of various cations. On the other hand, the present invention appropriately introduces alkaline earth metal oxides. Compared with alkali metal ions, due to the higher charge, the probability of alkaline earth metal ions being leached in an aqueous solution is smaller, which helps to improve the chemical stability of the glass without increasing the melting temperature.

[0045] In the present invention, the glass raw material preferably also includes 0-3wt% ZnO, more preferably 0-1wt%, most preferably 0.5wt%, and the mass percentage of the ZnO is not 0. The present invention introduces a small amount of ZnO to replace CaO to improve chemical stability without negatively affecting thermal stability. The ZnO is a network intermediate, and its specific role is related to its content. When the content is low, ZnO can be used as a body to strengthen the glass network, thereby reducing the probability of alkaline metal ions being dissolved, so that acid resistance and water resistance are improved. At the same time, due to Zn 2+ With large cation field strength, 2- The bond is stronger and has no negative impact on the water resistance of neutral borosilicate glass compared to other alkaline metal ions.

[0046] In the present invention, the mass ratio of Na2O to K2O is preferably 12-14.

[0047] In the present invention, the ratio of the sum of the masses of ZnO and CaO to the mass of BaO is preferably 0.7-4.

[0048] The present invention also provides a method for preparing the transparent medical neutral borosilicate glass according to the above technical solution, comprising the following steps:

[0049] Mixing the glass raw materials and the clarifier and melting them to obtain a glass melt;

[0050] The glass melt is sequentially subjected to pouring, first cooling, annealing treatment and second cooling to obtain the transparent medical neutral borosilicate glass.

[0051] The present invention mixes the glass raw materials and the clarifier and then melts them to obtain a glass melt.

[0052] In the present invention, the melting is preferably performed in an air atmosphere.

[0053] In the present invention, the melting process is preferably in the 25-700°C section, with a heating rate of 3-4°C / min; in the 700-1200°C section, the heating rate is 4-5°C / min; in the 1200-1650°C section, the heating rate is 5-10°C / min, and the temperature is kept for 1.5-2.5h. The present invention uses a segmented temperature control heating system to improve the boron volatilization problem to a certain extent and ensure the main properties of neutral borosilicate glass. Boron can increase the thermal stability and chemical stability of glass, but boron compounds generally have a low melting point and are prone to excessive volatilization at high temperatures, which has a negative impact on glass performance. The present invention promotes its integration into the glass as a network former under the condition of a fixed boron dosage by strictly controlling the temperature.

[0054] After obtaining the glass melt, the present invention sequentially performs pouring, first cooling, annealing treatment and second cooling on the glass melt to obtain the transparent medical neutral borosilicate glass.

[0055] The present invention has no particular limitation on the specific method of pouring, and any method well known to those skilled in the art may be used.

[0056] In the present invention, the cooling rate of the first cooling is preferably 700-800° C. / min.

[0057] In the present invention, the annealing treatment temperature is preferably 580-600° C., and the annealing time is preferably 2-3 hours.

[0058] In the present invention, the second cooling is preferably furnace cooling.

[0059] The present invention has no special limitation on the application of the transparent medical neutral borosilicate glass, and the application method familiar to those skilled in the art can be adopted.

[0060] In order to further illustrate the present invention, the transparent medical neutral borosilicate glass and the preparation method thereof provided by the present invention are described in detail below in conjunction with examples, but they should not be construed as limiting the protection scope of the present invention.

[0061] Example 1

[0062] The mass percentage of glass raw materials of transparent medical neutral borosilicate glass is: SiO2: 73.5wt%, B2O3: 9.5wt%, Al2O3: 6.0wt%, Na2O: 6.8wt%, K2O: 0.5wt%, CaO: 1.5wt%, BaO: 2.2wt%, clarifier NaCl (calculated separately): 0.5wt%, heated to a melting temperature of 1650°C in an air atmosphere at 25-700°C, a heating rate of 3°C / min, 700-1200°C, a heating rate of 4°C / min; 1200-1650°C, a heating rate of 5°C / min, and kept warm for 2h, quenched to 580°C at 700°C / min, kept warm for 2h for annealing, and cooled to room temperature with the furnace.

[0063] Example 2

[0064] The mass percentage of glass raw materials of transparent medical neutral borosilicate glass is: SiO2: 73.5wt%, B2O3: 9.5wt%, Al2O3: 6.0wt%, Na2O: 6.8wt%, K2O: 0.5wt%, BaO: 2.7wt%, ZnO: 1wt%, clarifier NaCl (calculated separately): 0.5wt%, heated to a melting temperature of 1650°C in an air atmosphere at 25-700°C, a heating rate of 4°C / min; 700-1200°C, a heating rate of 5°C / min; 1200-1650°C, a heating rate of 10°C / min, kept warm for 2h, suddenly cooled to 580°C at 800°C / min, kept warm for 2h for annealing, and cooled to room temperature with the furnace.

[0065] Example 3

[0066] The mass percentage of glass raw materials of transparent medical neutral borosilicate glass is: SiO2: 73.5wt%, B2O3: 9.5wt%, Al2O3: 6.0wt%, Na2O: 6.8wt%, K2O: 0.5wt%, CaO: 2.0wt%, BaO: 1.7wt%, clarifier NaCl (calculated separately): 0.5wt%, heated to a melting temperature of 1650°C in an air atmosphere at 25-700°C, a heating rate of 4°C / min; 700-1200°C, a heating rate of 4°C / min; 1200-1650°C, a heating rate of 10°C / min, kept warm for 2h, suddenly cooled to 580°C at 800°C / min, kept warm for 2h for annealing, and cooled to room temperature with the furnace.

[0067] Example 4

[0068] The mass percentage of glass raw materials of transparent medical neutral borosilicate glass is: SiO2: 73.5wt%, B2O3: 9.5wt%, Al2O3: 6.0wt%, Na2O: 6.8wt%, K2O: 0.5wt%, CaO: 3.0wt%, BaO: 0.7wt%, clarifier NaCl (calculated separately): 0.5wt%, heated to a melting temperature of 1650°C in an air atmosphere at 25-700°C, a heating rate of 4°C / min; 700-1200°C, a heating rate of 4°C / min; 1200-1650°C, a heating rate of 10°C / min, kept warm for 3h, suddenly cooled to 580°C at 800°C / min, kept warm for 2h for annealing, and cooled to room temperature with the furnace.

[0069] Figure 1 The physical pictures of the neutral borosilicate glass prepared in Examples 1 to 4, wherein (1) is Example 1, (2) is Example 2, (3) is Example 3, and (4) is Example 4. Figure 1It can be seen that the neutral borosilicate glasses prepared in Examples 1, 2, 3, and 4 are all colorless, transparent, and homogeneous, and no bubbles visible to the naked eye appear.

[0070] Comparative Example 1

[0071] A method for preparing neutral glass, as follows:

[0072] The mass percentages of the neutral borosilicate glass components are: SiO2: 78.0wt%, B2O3: 9.0wt%, Al2O3: 4.0wt%, Na2O: 5.0wt%, K2O: 1.0wt%, Li2O: 1.5wt%, CaO: 1.5wt%, heated to 1550°C in an air atmosphere, melted and kept warm for 350 minutes, then raised to 1580°C, kept warm for 30 minutes to complete clarification, suddenly cooled to 560°C, kept warm for 15 minutes for annealing, and cooled to room temperature with the furnace.

[0073] Comparative Example 2

[0074] A method for preparing borosilicate glass is as follows:

[0075] The mass percentages of the neutral borosilicate glass components are: SiO2: 73.84wt%, B2O3: 10.59wt%, Al2O3: 2.96wt%, Na2O: 6.85wt%, K2O: 0.53wt%, CaO: 0.91wt%, MgO: 0.01wt%, BaO: 1.06wt%, ZrO: 3.0wt%, ZnO: 0.25wt%. The glass was melted at 1580°C for 10 hours, and the molten glass was stirred with a platinum-rhodium alloy rod. When the temperature of the glass reached 1600°C, the stirring was stopped, and the glass was clarified by keeping it warm for 3 hours, and then formed.

[0076] The embodiment of the present invention can complete clarification by adding a clarifier without stirring, while comparative examples 1 and 2 both require stirring.

[0077] The main performance test methods are as follows:

[0078] The average linear thermal expansion coefficient of the strip glass sample was tested with reference to "YBB00202003-2015 Method for Determination of Average Linear Thermal Expansion Coefficient".

[0079] Refer to "YBB00342004-2015 Determination of glass resistance to boiling hydrochloric acid erosion" to test the acid resistance of the glass block.

[0080] The alkali corrosion resistance of the glass block is tested with reference to ISO 696-1991 Test method and classification for corrosion resistance of glass by boiling mixed alkali aqueous solution.

[0081] The alkali leaching amount of glass particles was tested with reference to ISO 719-1985 Test method and classification of water resistance of glass particles at 98°C.

[0082] The results are shown in Table 1. It can be seen that the neutral borosilicate glass obtained in Examples 1 to 4 of the present invention meets the relevant standards of medical glass in terms of thermal stability, acid resistance, alkali resistance and water resistance, and is a qualified medical neutral borosilicate glass, that is, acid resistance level 1, alkali resistance level A2, water resistance level HGB1, and linear thermal expansion coefficient is strictly less than 5×10 -7 / °C. Compared with Comparative Examples 1 and 2, the embodiment of the present invention optimizes the ratio of the network modifier, so that the linear thermal expansion coefficient of the obtained glass is lower, and the resistance to temperature change stress is stronger, so it has a wider allowable temperature range.

[0083] Table 1 Performance test results of the glasses obtained in Examples 1 to 4 and Comparative Examples 1 to 2

[0084]

[0085] Comparing the preparation processes, the embodiment of the present invention requires a shorter holding time at the clarification temperature. A large amount of SiO2 is the basis for the excellent physical and chemical properties of neutral borosilicate glass, but it also brings negative effects such as high viscosity of the glass liquid at high temperature, difficulty in homogenization and clarification. Therefore, it is necessary to increase the clarification temperature or extend the clarification time, which will inevitably cause fuel waste. The embodiment of the present invention adds a small amount of clarifier NaCl, and the melting and clarification can be completed within 1 to 2 hours.

[0086] The above description is only a preferred embodiment of the present invention and does not limit the present invention in any form. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention, and these improvements and modifications should also be regarded as the protection scope of the present invention.

Claims

1. A transparent medical neutral borosilicate glass, characterized in that: It is made from a clarifier and glass raw materials, wherein the glass raw materials are the following components in mass percentage: 73.5% SiO2, 9.5% B2O3, 6.0% Al2O3, 6.8% Na2O, 0.5% K2O, 2.0% CaO and 1.7% BaO; The clarifier is NaCl, the mass fraction of the NaCl is 0-2% of the glass raw material and the mass fraction of the NaCl is not 0; The method for preparing the transparent medical neutral borosilicate glass comprises the following steps: Mixing the glass raw materials and the clarifier and melting them to obtain a glass melt; The glass melt is sequentially subjected to pouring, first cooling, annealing treatment and second cooling to obtain the transparent medical neutral borosilicate glass; The melting process is as follows: the temperature is from 25 to 700°C, the heating rate is 3 to 4°C / min; the temperature is from 700 to 1200°C, the heating rate is 4 to 5°C / min; the temperature is from 1200 to 1650°C, the heating rate is 5 to 10°C / min, and the temperature is kept for 1.5 to 2.5 hours.

2. The method for preparing the transparent medical neutral borosilicate glass according to claim 1, characterized in that: The following steps are involved: Mixing the glass raw materials and the clarifier and melting them to obtain a glass melt; The glass melt is sequentially subjected to pouring, first cooling, annealing treatment and second cooling to obtain the transparent medical neutral borosilicate glass; The melting process is as follows: the temperature is from 25 to 700°C, the heating rate is 3 to 4°C / min; the temperature is from 700 to 1200°C, the heating rate is 4 to 5°C / min; the temperature is from 1200 to 1650°C, the heating rate is 5 to 10°C / min, and the temperature is kept for 1.5 to 2.5 hours.

3. The preparation method according to claim 2, characterized in that: The cooling rate of the first cooling is 700-800° C. / min.

4. The preparation method according to claim 2, characterized in that: The annealing treatment is carried out at a temperature of 580 to 600° C. and for a time of 2 to 3 hours.